Bulls Storm Surging Novavax, Inc. (NVAX)

Novavax, Inc. (NVAX) calls are trading at an accelerated pace

Digital Content Group
Mar 27, 2015 at 1:57 PM
facebook twitter linkedin


Novavax, Inc. (NASDAQ:NVAX) is gaining fast today, adding 8.8% to land at $8.25, thanks to a "buy" initiation and $10 price target from Citigroup. Also, the brokerage firm expressed optimism over a pair of vaccines the company is developing. Call buying has since picked up in the stock's options pits, with the contracts crossing at an 80% mark-up to usual intraday volumes. The most popular contract by a wide margin is the April 8 call, and data gives the impression of buy-to-open activity. These traders are betting on the shares to move further above the $8 level by the close on Friday, April 17, when the options expire.

It's not a surprise to see NVAX's traders rushing to pick up calls. According to the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.40 -- which ranks in the 8th percentile of its annual range -- short-term speculators are more call-skewed than normal.

Analysts have made their positive feelings on the stock clear, with all five covering brokerage firms rating it a "strong buy." Also, Novavax, Inc.'s (NASDAQ:NVAX) average 12-month price target of $10.38 stands in territory not charted in roughly 13 years. Year-to-date, NVAX has added 39%.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners